Purslane and Metformin Combination Shows Potential for Improving Cognitive Function in Type 2 Diabetes Patients

Recent research indicates a potential new treatment approach for cognitive decline linked to type 2 diabetes. The study investigated a combination therapy using purslane and metformin, common diabetes treatments, and its effects on cognitive function.

The research explored how purslane and metformin, when used together, could improve cognitive outcomes for individuals with T2DM. The findings suggest a possible innovative strategy in managing the cognitive challenges associated with this widespread chronic condition.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: May 3, 2026

Author

GOAI